Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

WELL Health to Acquire MyHealth and Become Largest Outpatient Medical Clinic Owner-Operator and Leading Multi-disciplinary Telehealth Service Provider in Canada

Canada NewsWire June 7, 2021

New revolutionary tool for cancer diagnostics

PR Newswire June 7, 2021

EmpowerPharm becomes the first Canadian pharmaceutical company with a certified GMP facility fully dedicated to manufacture CBD tablets and capsules

Canada NewsWire June 7, 2021

United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia

PR Newswire June 7, 2021

Ironhand 2.0 - The new version of award-winning exoskeleton glove

PR Newswire June 7, 2021

Elekta and Philips deepen strategic partnership in precise and individualized oncology care

PR Newswire June 7, 2021

Article on CD40 agonistic antibodies published in Expert Opinion on Biological Therapy

PR Newswire June 7, 2021

Janssen Affiliate Cilag GmbH International Discontinues Collaboration and License Agreement with argenx for Cusatuzumab

PR Newswire June 7, 2021

OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting

PR Newswire June 6, 2021

Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication

PR Newswire June 6, 2021

Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021

PR Newswire June 6, 2021

Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries

PR Newswire June 6, 2021

Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021

PR Newswire June 6, 2021

Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting

PR Newswire June 6, 2021

Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021

PR Newswire June 6, 2021

Antech helps veterinary teams deliver excellent pet care more efficiently by advancing core diagnostics

PR Newswire June 6, 2021

Antech Digital Cytology Scanner Now Available

PR Newswire June 6, 2021

Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX(TM), phase III results at ASCO 2021

Canada NewsWire June 5, 2021

FDA Approves First Treatment for Patients with Plasminogen Deficiency, a Rare Genetic Disorder

PR Newswire June 4, 2021

Amgen To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference

PR Newswire June 4, 2021